Cargando…
Regulated Expression of CCL21 in the Prostate Tumor Microenvironment Inhibits Tumor Growth and Metastasis in an Orthotopic Model of Prostate Cancer
Currently there are no curative therapies available for patients with metastatic prostate cancer. Thus, novel therapies are needed to treat this patient population. Immunotherapy represents one promising approach for the elimination of occult metastatic tumors. However, the prostate tumor microenvir...
Autores principales: | Yousefieh, Nazita, Hahto, Suzanne M., Stephens, Amber L., Ciavarra, Richard P. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2787929/ https://www.ncbi.nlm.nih.gov/pubmed/19418243 http://dx.doi.org/10.1007/s12307-009-0021-z |
Ejemplares similares
-
Raloxifene Suppresses Tumor Growth and Metastasis in an Orthotopic Model of Castration-Resistant Prostate Cancer
por: Palmer, Hannah, et al.
Publicado: (2022) -
Alendronate decreases orthotopic PC-3 prostate tumor growth and metastasis to prostate-draining lymph nodes in nude mice
por: Tuomela, Johanna M, et al.
Publicado: (2008) -
A humanized orthotopic tumor microenvironment alters the bone metastatic tropism of prostate cancer cells
por: McGovern, Jacqui A., et al.
Publicado: (2021) -
Aminomethylphosphonic acid inhibits growth and metastasis of human prostate cancer in an orthotopic xenograft mouse model
por: Parajuli, Keshab Raj, et al.
Publicado: (2016) -
Impact of Immune Cells in the Tumor Microenvironment of Prostate Cancer Metastasis
por: Messex, Justin K., et al.
Publicado: (2023)